Cardiac transplant donor heart allocation based on prospective tissue matching

Verdi J. DiSesa, Rebekah Mull, Elaine S. Daly, L. Henry Edmunds, Donna M. Mancini, Howard Eisen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The present priority scheme for the allocation of donor hearts based on patient acuity and waiting time contributes to the escalating costs of heart transplantation, ignores the potential outcome advantages of prospective tissue matching, and is vulnerable to manipulation. Costs have trebled in recent years, as recipients frequently spend weeks before transplantation as inpatients in intensive care units and become more susceptible to nosocomial complications. The findings from an international cooperative study suggest that patient survival is correlated with the level of histocompatibility (ie, human lymphocyte antigen [HLA]) matching. We observed a similar inverse association between retrospective fortuitous HLA matching and the risk of rejection in 39 patients undergoing heart transplantation over a 29-month period (p = 0.03 by nonparametric analysis). These observations prompted us to consider the feasibility of donor heart allocation based on the degree of HLA matching and waiting time alone. Current methods permit the accurate determination of HLA type in a matter of hours using donor peripheral blood alone. Human lymphocyte antigen typing, therefore, could be performed locally before organ harvesting, making issues of donor heart preservation irrelevant. We evaluated the extent of HLA matching that might be achieved practically. Forty-seven patients on our waiting list during calendar year 1991 were tested retrospectively for HLA matching with all geographically accessible 1991 heart donors identified by the United Network for Organ Sharing for all donors from hospitals east of the Mississippi River. Patients were matched for compatible blood type and six HLA antigens (two each for A, B, and DR) with 1,068 donors. For patients with blood type O (n = 30), 90% ( 27 30) had at least one donor with four antigens matched and 37% ( 11 30) and 20% ( 6 30) had at least one five- or six-antigen match, respectively. For patients with blood type A (n = 12) 100% ( 12 12) and 50% ( 6 12) had four- or five-antigen matches, respectively. Results were similar for blood type B (n = 2) and AB (n = 3) patients. A high degree of prospective HLA matching is achievable in heart transplantation with currently available technology. An allocation system based on matching and waiting time alone would be readily verifiable, would reduce the cost of heart transplantation by directing more hearts to outpatient recipients, and could improve outcome by achieving higher degrees of tissue compatibility. These factors constitute a rationale to consider other than the traditional triage criteria for the allocation of donor hearts.

Original languageEnglish (US)
Pages (from-to)1050-1053
Number of pages4
JournalThe Annals of Thoracic Surgery
Volume58
Issue number4
DOIs
StatePublished - Jan 1 1994

Fingerprint

Tissue Donors
Antigens
Lymphocytes
Heart Transplantation
Histocompatibility
Costs and Cost Analysis
Tissue and Organ Harvesting
Patient Acuity
Mississippi
Waiting Lists
Triage
Blood Donors
Rivers
Intensive Care Units
Inpatients
Outpatients
Transplantation
Technology
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

DiSesa, Verdi J. ; Mull, Rebekah ; Daly, Elaine S. ; Edmunds, L. Henry ; Mancini, Donna M. ; Eisen, Howard. / Cardiac transplant donor heart allocation based on prospective tissue matching. In: The Annals of Thoracic Surgery. 1994 ; Vol. 58, No. 4. pp. 1050-1053.
@article{92c4fed201384212906e467c2a80a3a9,
title = "Cardiac transplant donor heart allocation based on prospective tissue matching",
abstract = "The present priority scheme for the allocation of donor hearts based on patient acuity and waiting time contributes to the escalating costs of heart transplantation, ignores the potential outcome advantages of prospective tissue matching, and is vulnerable to manipulation. Costs have trebled in recent years, as recipients frequently spend weeks before transplantation as inpatients in intensive care units and become more susceptible to nosocomial complications. The findings from an international cooperative study suggest that patient survival is correlated with the level of histocompatibility (ie, human lymphocyte antigen [HLA]) matching. We observed a similar inverse association between retrospective fortuitous HLA matching and the risk of rejection in 39 patients undergoing heart transplantation over a 29-month period (p = 0.03 by nonparametric analysis). These observations prompted us to consider the feasibility of donor heart allocation based on the degree of HLA matching and waiting time alone. Current methods permit the accurate determination of HLA type in a matter of hours using donor peripheral blood alone. Human lymphocyte antigen typing, therefore, could be performed locally before organ harvesting, making issues of donor heart preservation irrelevant. We evaluated the extent of HLA matching that might be achieved practically. Forty-seven patients on our waiting list during calendar year 1991 were tested retrospectively for HLA matching with all geographically accessible 1991 heart donors identified by the United Network for Organ Sharing for all donors from hospitals east of the Mississippi River. Patients were matched for compatible blood type and six HLA antigens (two each for A, B, and DR) with 1,068 donors. For patients with blood type O (n = 30), 90{\%} ( 27 30) had at least one donor with four antigens matched and 37{\%} ( 11 30) and 20{\%} ( 6 30) had at least one five- or six-antigen match, respectively. For patients with blood type A (n = 12) 100{\%} ( 12 12) and 50{\%} ( 6 12) had four- or five-antigen matches, respectively. Results were similar for blood type B (n = 2) and AB (n = 3) patients. A high degree of prospective HLA matching is achievable in heart transplantation with currently available technology. An allocation system based on matching and waiting time alone would be readily verifiable, would reduce the cost of heart transplantation by directing more hearts to outpatient recipients, and could improve outcome by achieving higher degrees of tissue compatibility. These factors constitute a rationale to consider other than the traditional triage criteria for the allocation of donor hearts.",
author = "DiSesa, {Verdi J.} and Rebekah Mull and Daly, {Elaine S.} and Edmunds, {L. Henry} and Mancini, {Donna M.} and Howard Eisen",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0003-4975(94)90452-9",
language = "English (US)",
volume = "58",
pages = "1050--1053",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

Cardiac transplant donor heart allocation based on prospective tissue matching. / DiSesa, Verdi J.; Mull, Rebekah; Daly, Elaine S.; Edmunds, L. Henry; Mancini, Donna M.; Eisen, Howard.

In: The Annals of Thoracic Surgery, Vol. 58, No. 4, 01.01.1994, p. 1050-1053.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cardiac transplant donor heart allocation based on prospective tissue matching

AU - DiSesa, Verdi J.

AU - Mull, Rebekah

AU - Daly, Elaine S.

AU - Edmunds, L. Henry

AU - Mancini, Donna M.

AU - Eisen, Howard

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The present priority scheme for the allocation of donor hearts based on patient acuity and waiting time contributes to the escalating costs of heart transplantation, ignores the potential outcome advantages of prospective tissue matching, and is vulnerable to manipulation. Costs have trebled in recent years, as recipients frequently spend weeks before transplantation as inpatients in intensive care units and become more susceptible to nosocomial complications. The findings from an international cooperative study suggest that patient survival is correlated with the level of histocompatibility (ie, human lymphocyte antigen [HLA]) matching. We observed a similar inverse association between retrospective fortuitous HLA matching and the risk of rejection in 39 patients undergoing heart transplantation over a 29-month period (p = 0.03 by nonparametric analysis). These observations prompted us to consider the feasibility of donor heart allocation based on the degree of HLA matching and waiting time alone. Current methods permit the accurate determination of HLA type in a matter of hours using donor peripheral blood alone. Human lymphocyte antigen typing, therefore, could be performed locally before organ harvesting, making issues of donor heart preservation irrelevant. We evaluated the extent of HLA matching that might be achieved practically. Forty-seven patients on our waiting list during calendar year 1991 were tested retrospectively for HLA matching with all geographically accessible 1991 heart donors identified by the United Network for Organ Sharing for all donors from hospitals east of the Mississippi River. Patients were matched for compatible blood type and six HLA antigens (two each for A, B, and DR) with 1,068 donors. For patients with blood type O (n = 30), 90% ( 27 30) had at least one donor with four antigens matched and 37% ( 11 30) and 20% ( 6 30) had at least one five- or six-antigen match, respectively. For patients with blood type A (n = 12) 100% ( 12 12) and 50% ( 6 12) had four- or five-antigen matches, respectively. Results were similar for blood type B (n = 2) and AB (n = 3) patients. A high degree of prospective HLA matching is achievable in heart transplantation with currently available technology. An allocation system based on matching and waiting time alone would be readily verifiable, would reduce the cost of heart transplantation by directing more hearts to outpatient recipients, and could improve outcome by achieving higher degrees of tissue compatibility. These factors constitute a rationale to consider other than the traditional triage criteria for the allocation of donor hearts.

AB - The present priority scheme for the allocation of donor hearts based on patient acuity and waiting time contributes to the escalating costs of heart transplantation, ignores the potential outcome advantages of prospective tissue matching, and is vulnerable to manipulation. Costs have trebled in recent years, as recipients frequently spend weeks before transplantation as inpatients in intensive care units and become more susceptible to nosocomial complications. The findings from an international cooperative study suggest that patient survival is correlated with the level of histocompatibility (ie, human lymphocyte antigen [HLA]) matching. We observed a similar inverse association between retrospective fortuitous HLA matching and the risk of rejection in 39 patients undergoing heart transplantation over a 29-month period (p = 0.03 by nonparametric analysis). These observations prompted us to consider the feasibility of donor heart allocation based on the degree of HLA matching and waiting time alone. Current methods permit the accurate determination of HLA type in a matter of hours using donor peripheral blood alone. Human lymphocyte antigen typing, therefore, could be performed locally before organ harvesting, making issues of donor heart preservation irrelevant. We evaluated the extent of HLA matching that might be achieved practically. Forty-seven patients on our waiting list during calendar year 1991 were tested retrospectively for HLA matching with all geographically accessible 1991 heart donors identified by the United Network for Organ Sharing for all donors from hospitals east of the Mississippi River. Patients were matched for compatible blood type and six HLA antigens (two each for A, B, and DR) with 1,068 donors. For patients with blood type O (n = 30), 90% ( 27 30) had at least one donor with four antigens matched and 37% ( 11 30) and 20% ( 6 30) had at least one five- or six-antigen match, respectively. For patients with blood type A (n = 12) 100% ( 12 12) and 50% ( 6 12) had four- or five-antigen matches, respectively. Results were similar for blood type B (n = 2) and AB (n = 3) patients. A high degree of prospective HLA matching is achievable in heart transplantation with currently available technology. An allocation system based on matching and waiting time alone would be readily verifiable, would reduce the cost of heart transplantation by directing more hearts to outpatient recipients, and could improve outcome by achieving higher degrees of tissue compatibility. These factors constitute a rationale to consider other than the traditional triage criteria for the allocation of donor hearts.

UR - http://www.scopus.com/inward/record.url?scp=0028061689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028061689&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(94)90452-9

DO - 10.1016/0003-4975(94)90452-9

M3 - Article

C2 - 7944748

AN - SCOPUS:0028061689

VL - 58

SP - 1050

EP - 1053

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -